What to expect from PEGS Europe 2023: Day 3
Drug Discovery World
NOVEMBER 13, 2023
Nageatte Ibrahim, MD, Vice President, Oncology & Global Clinical Development, MSD, on: ‘The new age of immunotherapy: From checkpoint inhibitors to vaccines’. Dennis Verzijl, PhD, Principal Scientist, Genmab, on: ‘Kinetic antibody characterisation on challenging targets’.
147 
Let's personalize your content